𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatment

✍ Scribed by Villela, Renata ;Yuen, Sai Yan ;Pope, Janet E. ;Baron, Murray ;,

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
170 KB
Volume
59
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The implications of variation in outcome
The implications of variation in outcome between health professionals for the design and analysis of randomized controlled trials
✍ Chris Roberts πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 2 views

Methodological work on randomized trials has largely concerned pharmacological interventions in which the e!ects of the attending health professional may be regarded as minor. In other clinical settings, such as surgery, talk or physical therapies, sta! speci"c variation may make generalization prob

Double-blind, placebo-controlled trial t
Double-blind, placebo-controlled trial to assess the efficacy and tolerability of mepartricin in the treatment of BPH
✍ Denis, Louis; Pagano, Francesco; Nonis, Atanasio; Robertson, Chris; Romano, Paol πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

BACKGROUND. Mepartricin, a semisynthetic polyene derivative with a favorable effect on urethro-prostatic function, was clinically evaluated, adopting the diagnostic and research criteria recommended by the First International Consultation on BPH. METHODS. A multicenter, randomized, double-blind, par

A multicenter, prospective, randomized,
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
✍ Rachel K. Hoyles; Ross W. Ellis; Jessica Wellsbury; Belinda Lees; Pauline Newlan πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 156 KB πŸ‘ 2 views

## Abstract ## Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic sclerosis (SSc) has hampered an evidence‐based approach to treatment. This RCT was undertaken to investigate the effects of intravenous (IV) cyclophosphamide (CYC) followed by azathioprine (A